2020 annual financial data

INmune Bio 2020 Financial results

Direct answer

Revenue was 10,916 USD.

Operating income was -12,227,676 USD and net income was -12,099,159 USD.
Operating cash flow was -8,943,646 USD.

Get free INmune Bio email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
10,916 USD
Operating income
-12,227,676 USD
Net income
-12,099,159 USD
Operating cash flow
-8,943,646 USD